Science Board to the Food and Drug Administration Advisory Committee; Amendment of Notice

---
identifier: "/us/fr/01-8979"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Science Board to the Food and Drug Administration Advisory Committee; Amendment of Notice"
title_number: 0
title_name: "Federal Register"
section_number: "01-8979"
section_name: "Science Board to the Food and Drug Administration Advisory Committee; Amendment of Notice"
positive_law: false
currency: "2001-04-12"
last_updated: "2001-04-12"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "01-8979"
document_type: "notice"
publication_date: "2001-04-12"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
fr_citation: "66 FR 18957"
fr_volume: 66
fr_action: "Notice."
---


#  Science Board to the Food and Drug Administration Advisory Committee; Amendment of Notice

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Notice.

**SUMMARY:**

The Food and Drug Administration (FDA) is announcing an amendment to the notice of a public meeting of the Science Board to the Food and Drug Administration Advisory Committee. The meeting was announced in the *Federal Register* of March 23, 2001 (65 FR 16253). The amendment is being made to reflect changes in the *Agenda* portion of the meeting notice. The time for the open public hearing and open committee discussion has been changed. This meeting is open to the public. There are no other changes.

**FOR FURTHER INFORMATION CONTACT:**

Susan Bond, Office of the Commissioner, Office of Science Coordination and Communication (HF-33), Food and Drug Administration, 5600 Fishers Lane, rm. 17-35, Rockville, MD 20857, 301-827-6687, or FDA  Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 12603. Please call the Information Line for up-to-date information on this meeting.

**SUPPLEMENTARY INFORMATION:**

In the *Federal Register* of March 23, 2001 (65 FR 16253), FDA announced that a meeting of the Science Board to the Food and Drug Administration Advisory Committee would be held on April 13, 2001, and that the open public hearing would be held from 1 p.m. to 1:30 p.m. and the open committee discussion would be held from 1:30 p.m. to 4:30 p.m. On page 16253, in the second column, the *Agenda* portion of this meeting notice is amended to read as follows:

*Agenda* : Open committee discussion, 8:30 a.m. to l p.m.; open public hearing, 1 p.m. to 2 p.m.; open committee discussion, 2 p.m. to 4:30 p.m.* * *

Dated:April 2, 2001.

Linda A. Suydam,

Senior Associate Commissioner.